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Nutritional management of blood glucose levels is a strategic target in the prevention and management of type 2 diabetes
mellitus (T2DM). To implement such an approach, it is essential to understand the effect of food on glycemic regulation
and on the underlying metabolic derangements. This comprehensive review summarizes the results from human dietary
interventions exploring the impact of dietary components on blood glucose levels. Included are the major macronutrients;
carbohydrate, protein and fat, micronutrient vitamins and minerals, nonnutrient phytochemicals and additional foods
including low-calorie sweeteners, vinegar, and alcohol. Based on the evidence presented in this review, it is clear that
dietary components have significant and clinically relevant effects on blood glucose modulation. An integrated approach
that includes reducing excess body weight, increased physical activity along with a dietary regime to regulate blood
glucose levels will not only be advantages in T2DM management, but will benefit the health of the population and limit the
increasing worldwide incidence of T2DM.
Keywords Postprandial glycemia, diabetes, human dietary intervention, insulin resistance, insulin sensitivity.
INTRODUCTION
Around 366 million people worldwide have diabetes and
this is projected to reach 552 million by 2030 (Whiting et al.,
2011). Diabetes is a leading cause of death in developed
countries and is predicted to become epidemic in newly
industrialized nations. Additionally, poorly controlled diabe-
tes is a major factor in several serious disorders including
macrovascular disease, vision loss, renal failure, neuropathy,
and amputations (Diabetes Control and Complications Trial
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Research Group, 1993; Ohkubo et al., 1995; Haffner et al.,
1998; Niskanen et al., 1998; UK Prospective Diabetes Study
Group, 1998; Huxley et al., 2006). Nutritional management
of blood glucose dysregulation is a strategic target, as there
is mechanistic evidence to suggest that elevated blood glu-
cose levels contribute toward development of type 2 diabetes
mellitus (T2DM) (Blaak et al., 2012). Moreover, high blood
glucose levels, including values that are below the cutoff for
the diagnosis of diabetes, have been shown to be associated
with an increased risk of cardiovascular events. This relation-
ship applies not only to fasting values but also to other
markers of glucose homeostasis, which reflect blood glucose
control in the postprandial period (after a glucose load or
meal) or in a longer time frame, including both fasting and
postprandial conditions over a prolonged period (glycated
haemoglobin; HbA1c) (Heianza et al., 2011). Adoption of a
nutritional approach could deliver a cost-effective T2DM
prevention and management strategy, applicable across the
population. However, to implement a successful strategy and
provide clear guidance, it will be essential to understand the
effect of food on the underlying metabolic derangements.
Particular foods are implicated with increased or reduced
incidence of T2DM and their macro-, micro-, and not-nutri-
ent composition along with their energy content are all con-
sidered to be contributors to glucose homeostasis (Fig. 1).
This comprehensive review will focus on the evidence from
human dietary interventions, demonstrating that particular
food components have significant and clinically relevant
effects on blood glucose regulation.
Search Strategy
A systematic and comprehensive review of the literature
was undertaken using the highest quality data from the fol-
lowing bibliographic databases: MEDLINE (PubMed) and
Web of Knowledge (or Science). These databases were
searched for intervention trials investigating the effect of
nutrients in postprandial hyperglycemia in T2DM patients or
obese or control subjects with an explicit strategy for identi-
fying data for extraction and summarizing the data. The
search was conducted by combination (using Boolean opera-
tors) of the search terms of: “postprandial” C “specific mac-
ronutrient or other substance” and further refined by adding:
“glucose” or “hyperglycemia” or “insulin sensitivity” or
“insulin resistance.” Outputs were restricted to those com-
pleted studies only published in English. Terminology and
quality of evidence was assigned according to guidelines
from Oxford Centre for Evidence Based Medicine available
at http://www.cebm.net/?oD1116. Strategy for identifying
data for extraction and summarizing study findings are
detailed in Tables 1–9 and include: Type of Study, Food
source (including physical characteristics and delivery),
Control, Population Group, Methodology, Study Duration,
Primary and Secondary Outcomes, and References. In addi-
tion to inclusion of data regarding PPG, outputs considering
impact of dietary components on blood glucose regulation
were also included, as this was considered to be relevant.
The search exclusion criteria were type 1 diabetes mellitus
(T1DM), gestational diabetes, diabetes insipidus, infants and
Figure 1 Potential for dietary factors to reduce blood glucose levels and impact on b-cell function and associated biomarkers.GSIS, glucose-stimulated insulin
secretion.












































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































pediatric studies, although reference has been made to these
studies for discussive purposes.
Impact of Macronutrients on Blood Glucose Levels
Dietary Carbohydrates and Glycemic Control
By promoting subclinical inflammation, chronic hyper-
glycemia is a major contributor to endothelial damage, pro-
viding a link between diabetes and cardiovascular disease
(Ceriello, 2004). It has been suggested that oscillatory post-
prandial glycemic fluctuations are particularly detrimental
in relation to interleukin 6 expression, indicating that foods
which release their carbohydrates at a slow rate to the
blood are to be preferred. Available intervention studies
regarding the impact of dietary Glycemic Index (GI), or
Glycemic Load (GL D GI £ the amount of carbohydrates
per portion) on glycemic control in subjects with diabetes
was compiled in an extensive Cochrane review in 2009
(Thomas and Elliott, 2009). Data from 11 intervention stud-
ies lasting four weeks or longer were included and sub-
jected to meta-analysis. The overall conclusion was that
low GI diets improved diabetic control and reduced HbA1c
to an extent that was comparable to that seen following
medication in newly diagnosed T2DM subjects. It was also
put forward that a low GI diet may improve whole body
peripheral insulin sensitivity (Rizkalla et al., 2004), and
reduce the number of hypoglycemic events (Gilbertson
et al., 2001). Of interest in this context is that hypoglyce-
mia may be an additional risk factor for cardiovascular
disease in children with type 1 diabetes, independently of
HbA1c (Pena et al., 2012). Consequently, carbohydrate
foods that promote low but sustained blood glucose levels
may be considered advantageous with regard to metabolic
control of diabetes and possibly reduce risk of future car-
diovascular events.
One potential point for criticism of the GI concept is that
the glycemic impact of foods may be markedly affected by
certain meal components. This has been shown in healthy sub-
jects when adding, e.g., certain proteins or lipids to mixed
meals (Wolever and Bolognesi, 1996). Consequently, adding
whey and/or certain amino acids to a meal may substantially
reduce the glycemic excursion in healthy and T2DM subjects
(Frid et al., 2005; Nilsson et al., 2007; Gunnerud et al., 2012a,
2012b). However, for foods and meals rich in carbohydrates it
appears as if the GI of mixed meals can be predicted from the
component foods in healthy subjects indicating that for carbo-
hydrate-rich meals the effects of additive components of GI
are minor. This has also been demonstrated in T2DM subjects
(J€arvi et al., 1995; Robert and Ismail, 2012). The authors con-
cluded that generally, the single foods were ranked similarly
to the mixed meals, supporting the utility of the GI concept
also for mixed meals in T2DM subjects (Robert and Ismail,
2012).
The GI of foods is influenced by the type and amount of
dietary fiber (DF). In a study by J€arvi and coworkers (J€arvi
et al., 1999), a four-week intervention was performed in
T2DM subjects comparing a high versus low GI diet, using a
cross-over design. The differences in GI of the diets were
achieved by manipulating the food structure, thus essentially
maintaining the same food composition- including that of the
Table 5 Dietary vitamins and minerals and postprandial control









Vitamin E, vitamin C
and N-acetyl cysteine




































4 m HbA1c fasting Glc
and insulin;
2 h Glc and insulin
HbA1c, fasting, 2 h Glc and
insulin significantly reduced
in patients supplemented with








500 mg/d 10 m fasting and PPG fasting Glc and PPG improved
in >90% of subjects, and
similar improvements occurred
after 1–10 months. Fasting Glc
level and PPG lowered in 1
month and remained
significantly lower in
the following 9 months.
DB, double blind; SB, single blind; Cr, chromium; NS, no significant effect; IR, insulin response; WB, white bread; T2DM, type 2 diabetes; Glc, glucose; HDL,
high-density lipoprotein; PPG postprandial glycemia; BMI, body mass index (kg m¡2; expressed as mean unless otherwise specified).

































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































DF, but with different rates of digestion and absorption of the
available carbohydrates. It was concluded, that the low GI diet
with slow release carbohydrates lowered the glucose and insu-
lin responses throughout the day and improved the lipid profile
and capacity for fibrinolysis, suggesting a therapeutic potential
of such a diet in diabetes.
The impact of carbohydrate foods on blood glucose levels
is affected by a range of food factors, e.g., the type of carbo-
hydrate, the food form, type and amount of DF, and the pres-
ence of certain food components capable of interfering with
the digestive and/or absorptive mechanisms. As for the roles
of sugars on glycemic regulation in diabetic subjects,
Wheeler and Pi-Sunyer published a review in 2008, which is
still valid (Wheeler and Pi-Sunyer, 2008). One of their mes-
sages was that adding an amount of sugar up to 10% of total
energy to the diet did not negatively influence glycemic regu-
lation as measured by HbA1c. Another message put forward
by the same authors was that high-fructose corn syrup should
be considered as sucrose rather than fructose when included
in the diabetic diet, since it most often consist of equal
amounts of glucose and fructose (Wheeler and Pi-Sunyer,
2008). Regarding the effects of fructose on glycemic control
in diabetes, Cozma et al., recently published a meta-analysis
(Cozma et al., 2012). Their aggregated analyses of short-
term controlled feeding trials revealed that isocaloric fruc-
tose replacement of other carbohydrates (mainly starch and/
or sucrose) resulted in clinically significant improvements in
glycemic control, without significant effects on insulin, when
including both type 1 and type 2 diabetic individuals. In
stratified analysis, however, the reduction in glycated albu-
min and/or haemoglobin was only significant in people with
type 1 diabetes. There are certainly trends toward positive
outcomes on glycemia regulation also for individuals with
T2DM, but larger and longer trials of higher quality are war-
ranted to establish such associations (Cozma et al., 2012).
However, it should be taken into account that a higher intake
of sucrose or fructose should not be recommended to people
with diabetes or other conditions of impaired blood glucose
regulation, in view of a potential detrimental impact on body
weight, insulin sensitivity, and blood lipids (Johnson et al.,
2009; Stanhope et al., 2009).
Effect of Carbohydrate Structure and Properties
Chemical composition as well as the degree of gelatiniza-
tion may play a role for glycemic responses to starchy foods.
Most of the knowledge concerning the differences in PPG to
carbohydrates and carbohydrate foods stem from studies in
healthy subjects. Information regarding the GI features of car-
bohydrate foods is available in the international GI tables
(Atkinson et al., 2008), where studies in diabetic subjects are
presented.
Amylose-amylopectin ratio in starch: In a study of par-
boiled rice of a high-amylose (27%) variety, it was suggested
that a combination of the high-amylose rice and formation of
stable amylose-lipid complexes of the complex II type were
responsible for substantial lowering of GI (Larsen et al.,
2000). Furthermore, the results indicated that the severity of
processing during parboiling may be an important tool to
reduce the GI of rice. In bread products, the use of wheat
(Hallstrom, Sestili et al., 2011), barley (Liljeberg, A

kerberg
et al., 1996), and corn (Granfeldt, Drews et al., 1995) varieties
with elevated amylose contents have been reported to have
increased contents of resistant starch (RS). In addition to the
formation of an enzyme-resistant starch fraction in bread with
elevated amylose content, a slowly digestible starch fraction
appears to be formed, as judged from decreased PPG in
healthy subjects. When combining the use of cereal varieties
with elevated amylose contents with baking at pumpernickel
conditions (low temperature-long time), the formation of RS is
promoted even more (Hallstr€om et al., 2011). Some suggested
mechanisms behind the increased RS-formation are: a com-
pact structure that results in restricted starch swelling and gela-
tinization, formation of amylose-lipid, or amylose-protein
complexes, or encapsulation of gelatinized starch between
layers of RS.
Native versus gelatinized starch: Processing by heat is
common in the manufacturing of cereal products. During heat
treatment the starch is more or less completely gelatinized.
However, although the degree of gelatinization may be rather
low, the rate of amylolysis and thus the glycemic response
appear to increase rapidly. This has been shown for, e.g., oat
flakes in healthy subjects (Granfeldt, Hagander et al., 1995;
Granfeldt, Eliasson et al., 2000). A possibility to lower the
glycemic response to starchy food is by using native starches,
rather than gelatinized or partly gelatinized forms. The use of
uncooked corn starch to prevent nocturnal hypoglycemia in
diabetic children is one example of how glycemic features of a
food product can be optimized by a conscious choice of ingre-
dients. Thus, in a study by Kaufman and Devgan (1996), the
frequency of nocturnal and before breakfast hypoglycemic epi-
sodes was significantly reduced in type 1 diabetic subjects
after having uncooked corn starch included in an evening
snack, compared with their normal snack without such starch.
Chemically modified starch: Hydrogenated starch hydroly-
sates (HSH) are used as bulking and nonreducing sweetening
agents in for example, candy and gums. When comparing the
glycemic response to glucose and two varieties of HSH in
both insulin- and noninsulin dependent diabetic subjects as
well as healthy individuals, the glycemia was significantly
reduced after the HSH-meals (Wheeler et al., 1990). Further-
more, when combining all the subjects, a difference in glyce-
mic responses between the two HSH-varieties could be
detected, pointing in favor of the HSH with shorter hydroge-
nated saccharide chains (HSH, 5875).
Intact botanical structure or physical form: As mentioned
above, studies in T2DM subjects have clearly indicated the
importance of food structure on PPG (J€arvi et al., 1995). In an
earlier study (d’Emden et al., 1987) the glycemic responses to
equi-carbohydrate portions of bread made from either white
DIET AND BLOOD GLUCOSE REGULATION 563
wheat or semolina, respectively, or spaghetti made from white
and whole grain wheat, respectively, were tested in a group of
noninsulin dependent diabetic subjects. No differences were
found in glycemic response between either forms of bread, or
either type of spaghetti, but both bread products showed higher
glucose responses than the spaghetti meals. Thus, it was con-
cluded that the physical form of the food was a major factor
influencing the glycemic response. Similarly, maintaining the
botanical structure of cereal kernels (Liljeberg et al., 1992) as
well as rice (Panlasigui and Thompson, 2006) intact has been
shown to reduce PPG. The importance of botanical structure
has recently been investigated in two semiacute studies in
healthy subjects (Nilsson et al., 2008a; Nilsson et al., 2008b).
Interestingly, it was revealed that the semiacute benefits of
barley kernels on daylong glycemia was lost when the kernels
were milled into flour and consumed as porridge (Nilsson
et al., 2008a). On the other hand, by mimicking the content of
DF and RS in barley kernel bread, a flour-based bread product
improved glucose tolerance in an overnight perspective study
(10 h), compared with a white wheat bread (Nilsson et al.,
2008b). The benefits observed on semiacute glucose tolerance
are mediated by mechanisms emanating from colonic fermen-
tation of the indigestible carbohydrate fraction.
In an earlier attempt to investigate the potential of deple-
tion and disruption of dietary fiber, Haber et al. (1977) com-
pared the postprandial blood glucose levels in healthy
subjects after intake of apples, fiber-disrupted apple puree
and fiber-free apple juice. The results showed that plasma
glucose rose to the same extent after all three meals, but
there was a substantial difference in the rebound fall with
the apple juice causing a marked hypoglycemia between
approximately 60–120 min after the meal. The postprandial
glucose response after intact apples did not fall below the
fasting level at any time point. In addition to its detrimental
effect on glucose regulation, the disruption and removal of
fiber also favored faster and easier ingestion, which may
promote over-eating of such products.
Course of glycemia: After reviewing the literature regard-
ing effects of available carbohydrates on blood glucose levels
in diabetic patients it is concluded that there are surprisingly
few studies focusing on carbohydrate foods. However, as
reported in the International tables of glycemic index (Atkin-
son et al., 2008), there is a high correlation between GI-values
derived from studies performed in healthy and diabetic sub-
jects, respectively. Therefore, much of the information on the
glycemic response of different foods gained in healthy people
may be relevant also to predict the impact of these foods on
blood glucose levels in diabetic patients. Another important
aspect to consider when discussing acute and semiacute glyce-
mia is to acknowledge not only the GI-value of a food product
but the course of glycemia. In 2009, the concept of glycemic
profile (GP) was introduced and is defined as the duration of
the incremental postprandial blood glucose response divided
by the blood glucose incremental peak (min mM¡1) (Rosen
et al., 2009). Rye products generally produced high GI-values
despite low insulin indices. When examining the course of gly-
cemia after rye products, there was a sustained blood glucose
increment beyond the 120 min used for GI-calculations,
resulting in a higher than expected GI-value. It has been sug-
gested that GP is more strongly correlated with insulin
response (both insulin index and insulin incremental peak)
compared with GI (Rosen et al., 2009; Rosen, €Ostman et al.,
2011). Taking into account also the avoidance of hypoglyce-
mia after high-GP food, this GP measure describing the course
of glycemia may also be interesting to apply to PPG and glyce-
mic regulation in diabetic subjects.
Dietary Fiber and Glycemic Control
Dietary fiber has traditionally been defined as edible plant
polysaccharides and lignin naturally occurring in foods, and
which are resistant to hydrolysis by human digestive enzymes
(Trowell et al., 1976). Later definitions of fiber in nutrition
have also included isolated fibers from food raw materials or
edible synthetic carbohydrates that are resistant to digestion
and absorption in the human small intestine but are partly or
completely fermentable in the colon, and display beneficial
physiological effects, i.e., improved bowel function, blood
cholesterol, and blood glucose attenuation (Raninen et al.,
2011). These beneficial effects, i.e., improvements in meta-
bolic and disease control, are essentially based on the domi-
nant attributes of different fiber types when passing through
the gastrointestinal tract.
Types of dietary fiber: Dietary fiber is chemically a hetero-
geneous group of compounds with variable molecular size and
different physicochemical properties, such as water solubility,
viscosity, cation exchange properties, organic acid absorption
and water-holding capacity (Eastwood and Morris, 1992;
Guillon and Champ, 2000). Several classifications for fiber
have been established (Slavin et al., 2009; Raninen et al.,
2011) in which the traditional one is based on water solubility
dividing fiber into soluble (pectins, gums, mucilages) and
insoluble (cellulose, hemicelluloses, lignin) fiber types.
Although solubility per se is an essential determinant of the
physiological responses, viscosity and fermentability are likely
to play a more pronounced role in the physiological benefits in
humans.
Major dietary sources of DF are whole grain cereals,
legumes, vegetables, and fruits, which include a wide variety
of different types of fiber. The strongest and most consistent
effects on reduced risk of developing T2DM are observed with
diets high in insoluble and often only moderately fermentable
cereal fiber, whereas fruits and vegetables, which are more
important sources for soluble/fermentable fiber, do not show
any protective effect on this outcome in meta-analyses of pro-
spective cohort studies (Weickert et al., 2006; de Munter
et al., 2007; Schulze et al., 2007).
However, most commonly used fiber supplements are pri-
marily soluble fiber types, such as guar gum, glucomannan,
xanthan gum, psyllium, pectin, alginate, b-glucan concentrates,
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and various fiber combinations (Vuksan et al., 2009; Papatha-
nasopoulos and Camilleri, 2010). To date, it has not been
investigated in long-term controlled human interventions
whether these agents influence the risk of developing T2DM.
Due to the diversity of DF in natural fiber sources it is gener-
ally recommended to adhere to these food sources to improve
daily DF intake, thereby also assuring the additional nutritional
qualities of a healthy diet. Even so, it is usually challenging to
meet the recommended DF intake. Therefore, fiber supple-
ments can play an important role in increasing DF intake but
also in managing daily glucose levels both in healthy individu-
als and individuals with impaired glucose metabolism. How-
ever, although the potential health benefits of different types
of DF are known, there is still no clear consensus about the
ideal composition and proportion for the consumption of the
major sources of DF.
Amount of fiber: In addition to the type of DF, the amount
of DF plays a marked role in acute glycemic and insulinemic
responses. For example, findings from studies using b-glucan
have shown that 4 g of soluble b-glucan appear to be a thresh-
old for a significant reduction in postprandial glucose and insu-
lin responses in healthy individuals (Granfeldt et al., 2008;
Juvonen et al., 2011), whereas in T2DM subjects somewhat
lower amounts may be sufficient (Tapola et al., 2005). How-
ever, the amount of fiber does not appear to explain the lower
postprandial insulin response observed after a meal containing
rye bread as compared to white wheat bread (Juntunen et al.,
2003). Furthermore, the food matrix, i.e., liquid or solid food
forms in which fiber is consumed and macronutrient content in
mixed meals can markedly affect postprandial glucose and
insulin responses, as described elsewhere in the text.
Postprandial trials on fiber foods and supplements:
Recently, an obvious reappearance in the research interest on
the role of DF in the regulation of glycemic and insulinemic
responses in individuals with T2DM has emerged. Until now,
a large number of postprandial studies involving different fiber
types, either in the form of unprocessed foods or as isolated
DF supplements, have been carried out in people with T2DM
(Table 1 & 2). Additionally, data are derived from a few lon-
ger-term dietary interventions in which either modified total
diets or individual fiber products were served to individuals
with T2DM for periods from two weeks up to one year
(Table 2).
The randomized short-term trials clearly indicate that espe-
cially soluble fibers with viscous properties (e.g., gluco-
mannan, guar gum, psyllium, b-glucan) exert acute
improvements in glucose and insulin responses in individuals
with T2DM (Table 1). Guar gum (GG), an example of such a
water-soluble nonstarch polysaccharide, has shown both glu-
cose and insulin lowering properties (Ellis et al., 1991; Golay
et al., 1995), and psyllium fiber administered to NIDDM
patients immediately before breakfast and dinner lowered
postprandial glucose by 14% at breakfast and 20% at dinner
compared to placebo. A second meal effect was observed at
lunch (served 5 h after breakfast), where glucose was 31%
lower compared with placebo. Psyllium’s ability to reduce gly-
cemia was not affected by the patients mode of therapy (diet-
treated or on oral hypoglycemic agents) (Pastors et al., 1991).
In the majority of these postprandial studies, relatively high
doses of single DF types have been used to produce significant
postprandial reduction especially in glucose but also in insulin
responses when compared with no or low-fiber test products
(Tappy et al., 1996; €Ostman et al., 2006; Kim et al., 2009).
The significant effects of DF on postprandial glucose are not
necessarily accompanied with similar insulin responses which
may partly result from the DF type or amount used in these
studies. Insoluble cereal fiber is nonviscous/gel-forming and,
therefore, does not directly influence GI. However, cereal fiber
has been shown to improve whole-body insulin sensitivity, an
effect that can be observed as short as 24 h after intake, i.e.,
second meal effect (Weickert et al., 2005; Nilsson et al.,
2008c, 2008d, 2008e, 2008f). Since many low-GI foods are
also rich in insoluble cereal fiber interpretation of the results is
often not straight forward (Weickert and Pfeiffer, 2009). It
is also worth to note that the food matrix in which the fiber is
incorporated may actually modulate the postprandial responses
(Brennan, 2005) so that the effect of the added fiber may be
partly masked (Sels et al., 1992). These examples highlight
the difficulties when trying to investigate the metabolic effects
of single components of complex foods (Weickert, 2012).
Semiacute effects: The presence of intrinsic DF in certain
cereal products has been shown to influence PPG in healthy
humans at a subsequent meal, through a mechanism involving
gut fermentation (Nilsson et al., 2008a, 2008b). Consequently,
provision of evening meals based on barley kernel bread sig-
nificantly lowered blood glucose excursions at a subsequent
standardized breakfast compared with an evening meal with
white bread. Also, markers of inflammation and insulin resis-
tance were lowered, and the incretin hormone GLP-1
increased at breakfast (Nilsson et al., 2008a). In the case of
barley, similar benefits on over-night glucose tolerance could
be mimicked by adding a similar amount and ratio of barley
DF and RS to white wheat bread. In contrast, a flour-based
whole grain barley evening meal failed to induce benefits the
subsequent morning (Nilsson et al., 2008c), indicating a role
of the combined barley DF and RS in case of the kernel-based
barley meal. Additionally, ingestion of boiled cereal kernels
from rye and barley in the morning, not only reduced the acute
PPG, compared with white bread, but additionally improved
PPG at two subsequent standardized meals in healthy subjects.
It is clear that cereal products rich in intrinsic DF may improve
day-long PPG (Nilsson et al., 2008b). It is put forward that
whereas the benefits of certain kernel-based products in the
10 h perspective is related to gut fermentation; benefits from
breakfast to lunch are probably mediated by the latent features
of the breakfast meal. In contrast to barley, most rye meals are
characterized by improved PPG, including both flour-based
and kernel-based products (Rosen et al., 2011). Interestingly,
in the case of rye, evidence of rapid gut fermentation is present
as judged from early postprandial increment in breath
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hydrogen excretion. Taken together, the botanical structure
and intrinsic composition of fermentable substrates seems
important for PPG at subsequent meals.
Longer-term interventions: Evidence from longer-term DF
interventions in T2DM subjects shows that relatively high
fiber levels can be consumed when given as unprocessed foods
(legumes, vegetables, whole grain cereals) without causing
gastrointestinal problems (Table 2). Both de Natale et al.
(2009) and Chandalia et al. (2000) noticed improved glycemic
control in T2DM subjects after feeding 4–6 weeks of diets sup-
plying 50–53 g of fiber per day. No adverse side effects were
reported. Studies lasting 6–12 months with diets containing
low-GI foods have produced rather negative results on fiber
effects, showing no effect on glycated hemoglobin levels in
T2DM subjects (Jenkins et al., 2008a, 2008b; Wolever et al.,
2008).
An 18-week randomized controlled intervention in healthy
subjects having increased intake of insoluble cereal fiber, sup-
plemented by cereal fiber extracts twice daily, significantly
improved whole-body insulin sensitivity, as measured using
euglycemic-hyperinsulinemic clamps (Weickert et al., 2011a,
2011b). A previous intervention by Pereira and colleagues
showed comparable results when investigating the effects of
whole grain diets on whole-body insulin sensitivity (Pereira
et al., 2002). Interestingly, the consumption of insoluble resis-
tant starch appears to result in comparable effects on insulin
sensitivity in healthy adults (Robertson et al., 2003; Robertson
et al., 2005) and in subjects with metabolic syndrome (John-
ston et al., 2010). It is worth noting that in some studies differ-
ent sorts of moderately fermentable insoluble cereal fiber and
insoluble resistant starch resulted in comparable improvements
of estimated insulin sensitivity 24 h after consumption of the
cereal. Fiber/starch extracts consumed in a second meal test,
indicated that colonic fermentation with the production of
SCFA was not the key factor conveying improved insulin sen-
sitivity in this setting (Weickert et al., 2005). Longer-term
studies with isolated fiber products have yielded conflicting
results. Schwab et al. (2006) gave 24–30 g soluble fiber in the
form of sugar beet pectin or synthetic polydextrose mixed
with drink for three months to 66 subjects of which 10 were
T2DM subjects, the rest having problems with glucose metab-
olism (IGT, IFG). They found no effect on fasting or on PPG
after a standardized breakfast. However, supplemental fructoo-
ligosaccharides (FOS), 20 g/d, given to subjects with idio-
pathic hyperglycemia reduced the glucose excursions
(Sorensen and Johansen, 2010).
Possible mechanisms of fiber effects: Soluble viscous fibers
play a marked role in managing postprandial glucose and insu-
lin levels via forming viscous gels by absorbing water and
thereby reducing gastric emptying (Marciani et al., 2001; Dar-
wiche et al., 2003; Sanaka et al., 2007) and rate of glucose
absorption (Dikeman and Fahey, 2006). Other suggested
explanations why high viscosity products reduce PPG are
altered intestinal motility, slower diffusion rate of starch diges-
tion products and reduced a-amylase accessibility (Leclere
et al., 1994). In addition, it has been shown in vitro that guar
gum inhibits a-amylase in a direct, noncompetitive way in the
first stage of the enzymatic degradation of starch (Slaughter
et al., 2002).
The mechanisms underlying the association of increased
fiber intake with improved glycemic control in longer term
studies (Hu et al., 2001; Schulze et al., 2007; Livesey et al.,
2008) are not fully understood, but may include also colonic
effects such as short chain fatty acid production by colonic fer-
mentation and concurrent liberation of phenolic compounds in
addition to the above mentioned altered postprandial gastric
and small intestinal functions (Lappi et al., in press; Vita-
glione et al., 2008). Improved whole-body insulin sensitivity
by insoluble cereal fiber was suggested to be related to inter-
ference with the digestion and/or absorption of dietary protein
and consequently reduced amino acid induced activation of
the mammalian target of rapamycin (mTOR) S6 kinase 1
(S6K1) signaling pathway (Weickert et al., 2006, 2011a,
2011b) that directly results in insulin resistance both in animal
models and human intervention studies (Krebs et al., 2002;
Um et al., 2004; Tremblay et al., 2005). Further mechanisms
that may be involved could be cereal-fiber induced binding of
bile acids and fiber-induced effects on gut hormones and
metabolite profiles but this will need to be investigated in
future studies.
Thus, these results suggest that acute consumption of foods
rich in soluble fiber or soluble fiber supplements is beneficial
especially for the postprandial glycemic control but also for
the insulinemic response. However, the number of studies
investigating the effects of DF on acute glucose and insulin
responses in T2DM subjects is still limited which limits inter-
pretation of the effects. Moreover, the relevance of acute post-
prandial effects needs to be studied with regard to long-term
health outcome; in this context also insoluble dietary fiber
seem to play an important role by improving glucose and/or
insulin homeostasis (Blaak et al., 2012).
Gut Microbiota and Glycemic Control
The gut microbiota is increasingly considered as a symbi-
otic partner for the maintenance of health. The human gut
harbours vast numbers of bacteria, around 1011 bacterial
cells per mL of contents (Diamant et al., 2011; Qin et al.,
2010). Specific strains of gut bacteria can be classified upon
their sequence analogy into phyla, gender, species, and sub-
species. More recently, Arumugam et al., have “clusterized”
the gut microbiota of individuals from different countries
and continents into three “enterotypes” identified by the var-
iation at the level of one of the three following genera: Bac-
teroides, Prevotella, and Ruminococcus (Arumugam et al.,
2011). Long-term dietary pattern may influence the propor-
tion of those enterotypes, the Prevotella group being associ-
ated with carbohydrates and fiber intake (Wu et al., 2010).
Bifidobacterium spp. represents an important and complex
group of bacteria whose presence is often associated with
566 W. R. RUSSELL ET AL.
beneficial health effects (Boesten and de Vos, 2008; Turroni
et al., 2009; Delzenne and Cani, 2011a, 2011b). The Bifido-
bacterium genus was poorly represented in the faecal sam-
ples of diabetic subjects compared with healthy individuals
(Wu et al., 2010). Another interesting bacterial species is
Faecalibacterium prausnitzii, which level is found to be
decreased in subjects with diabetes compared to nondiabetic
obese subjects. Additionally, F. prausnitzii is negatively
associated with inflammatory markers measured in the
serum of obese individuals before and after roux- and Y-
gastric bypass surgery (Furet et al., 2010). Related to the
gut microbiota, components of the bacterial membrane have
been incriminated in the development of inflammation and
this is associated with lipopolysaccharides (LPS), present in
gram negative bacteria (for review, see Cani and Delzenne,
2011). The level of serum LPS is increased approximately
two-fold in obese subjects and those with diabetes, or fed a
high-fat diet. This is considered to involve processes includ-
ing an increase in chylomicron formation (upon high fat
diet feeding), a decrease in gut barrier integrity, and/or a
decrease in alkaline phosphatase activity, which is the
enzyme responsible for the cleavage of the LPS in the intes-
tine. It is likely that the metabolic function of the gut micro-
biota could be important in the control of blood glucose,
even if much of the data have been mainly obtained in ani-
mal studies. The promoting effect of the gut microbiota on
intestinal glucose absorption has been suggested in germ-
free mice colonized with the saccharolytic Bacteroides the-
taiotaomicron: this effect supports the fact that events
occurring upon bacterial fermentation may have an effect in
the upper part of the gut, and can modulate digestible carbo-
hydrates availability (Hooper et al., 2001). The short chain
fatty acids produced upon carbohydrate fermentation in the
gut, reach host tissues where they may act as metabolic reg-
ulators or substrates. If propionate acts as gluconeogenic
substrate in the liver, it is also able, at least in vitro, to
counteract gluconeogenesis from lactate, thereby decreasing
hepatic glucose production. Dietary supplementation of
butyrate can prevent and treat diet-induced insulin resis-
tance in mouse. The mechanism of butyrate action is related
to promotion of energy expenditure and induction of mito-
chondria function (Gao et al., 2009). On the other hand, the
G-protein coupled receptors, GPR43 and 41, are both
expressed in endocrine L cells in the colon, and when acti-
vated by their physiological ligands, the short chain fatty
acids, they promote proglucagon expression, GLP-1 secre-
tion, and could thereby control insulin secretion and glucose
homeostasis (Tolhurst et al., 2012).
If the gut microbiota plays a role in the control of glycemia,
it would be interesting to modulate the gut microbiota compo-
sition. The transplantation of gut microbiota from diabetic ani-
mals to germ-free mice transfers the diabetic and obese
phenotype, thereby suggesting that the characteristics of the
gut microbiota of diabetic individuals per se could play a role
in the metabolic response to diet, and that gut microbial
transfer is effective (Delzenne et al., 2011). The proof of this
concept has recently been shown in humans. An allogenic fae-
cal transplantation assay was performed from a nonlean male
donor to individuals with metabolic syndrome, and this
“treatment” was shown to improve glucose tolerance and insu-
lin sensitivity after six weeks. Specific changes in the gut
microbiota composition were associated with the improvement
of health (Vrieze et al., 2012). It is clear that dietary
approaches influence the composition of the gut microbiota in
humans and for this reason, the following sections will cover
the potential interest of prebiotics and probiotics to control
blood glucose levels.
Prebiotics and Blood Glucose Regulation
Among dietary fiber, some oligo- and polysaccharides
exhibit prebiotic properties, a concept originally described by
Gibson and Roberfroid (1995) and recently revisited at the ini-
tiative of the ILSI prebiotic task force (Roberfroid et al.,
2010). This “prebiotic concept” is defined as the selective
stimulation of one or a limited number of microbial genus
(era)/species/strain(s) in the gut microbiota that confer(s)
health benefits to the host. Inulin-type fructans were the first
studied prebiotics that have repeatedly demonstrated the
capacity to stimulate the growth of bifidobacteria in both ani-
mals and in humans. Even if other bacteria may be promoted
or modulated on fructan administration, there is no proof that
the bifidobacteria are responsible per se for the health effect of
fructans, the bifidogenic effect appears as the “microbial sig-
nature” of those prebiotics. Other oligosaccharides such as gal-
actans, arabinoxylans and glucans have now been considered
as dietary fibers with prebiotic properties (Delzenne et al.,
2011).
The modulation of gut microbiota by using dietary prebiot-
ics in the control of blood glucose homeostasis has been evalu-
ated in experimental animal models of hyperglycemia,
associated or not with obesity (streptozotocin treatment rats,
obese leptin deficient or leptin resistant mice of rats, high fat/
and or high glycemic index diet). The data have been detailed
in a previous paper (Roberfroid et al., 2010). A decrease in
postprandial or post-oral glucose tolerance test is observed in
most of the models. The implication of gut peptides such as an
increase in L cell differentiation leading to an increase portal
GLP-1 may be involved in this effect, as shown in high fat fed
mice or rats (Delzenne et al., 2011), or more recently in ob/ob
mice (Everard et al., 2011). Data obtained in high-fat fed mice
treated with fructan-type prebiotics revealed an improvement
of hepatic insulin sensitivity and a decrease in fasting insuline-
mia that correlated with the increase in caecal Bifidobacteria
(Cani et al., 2008). A more detailed genomic analysis of the
gut microbiota in ob/ob mice treated with fructans as prebiot-
ics highlighted novel bacteria that could be associated with the
improvement of gut endocrine function (L cell number), such
as Faecalibacterium praustnitzii or Akkermansia muciniphila
(Everard et al., 2011). The increase in GLP-2 by L cells
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occurring in prebiotic-treated mice could, in turn, reinforce the
gut barrier integrity and thereby decreases inflammation in the
liver tissue. This effect also contributes to improved glucose
metabolism (Cani et al., 2009). However, in the Profimet study
whole-body insulin sensitivity (Weickert, 2012) was signifi-
cantly improved independent of various markers of colonic
fermentation, SCFA profiles in faecal samples, and dominant
groups of the gut microbiota (Weickert et al., 2011a, 2011b),
indicating that further factors were involved in conveying
improved insulin sensitivity upon the consumption of insolu-
ble cereal fiber.
Few papers have been published, which have focused on
the influence of prebiotics on glucose homeostasis in humans
(Table 3). Luo et al. (1996) were the first to show that 20 g of
short chain fructans given for four weeks in healthy subjects
decreased basal hepatic glucose production, but had no detect-
able effect on insulin-stimulated glucose metabolism. In
T2DM subjects, no significant modification of glucose homeo-
stasis (plasma glucose level or hepatic glucose production)
occurred in prebiotic-treated patients (Luo et al., 2000). In a
similar study conducted in hypercholesterolemic patients,
fructan-prebiotics reduced the PPI response, but the clinical
relevance of this effect remains unclear (Giacco et al., 2004).
A two-week supplementation with 16 g/day inulin-type fruc-
tans versus the same amount of maltodextrin as placebo, was
able to increase GLP-1 production, and to lessen postprandial
glucose response after a standardized breakfast (Cani et al.,
2009a). Increases in gut peptides have also been shown in
obese individuals treated with prebiotics. This effect was
related to improvement of satiety, but the relation with glucose
homeostasis was not reported in this study (Parnell and Reimer
2009). Glycemia was not significantly modified in obese indi-
viduals subjected to low-calorie diet completed with Jerusalem
artichoke concentrate containing oligofructose as prebiotic,
whereas an improvement of HOMA-IR was observed in
treated obese adult women (Antal et al., 2008). If there are
some positive effects of a prebiotic intervention, there is a lack
of information relating the improvement of glucose response
and to changes in gut microbiota composition and/or activity
in humans or in diabetic/obese subjects. Those studies are
needed to evaluate the relevance of microbiota in the manage-
ment of glucose homeostasis.
Probiotics and Blood Glucose Regulation
A number of observations have led to speculation that pro-
biotics, defined as “live microbes which, when administered in
adequate amounts, confer a health benefit on the host” (FAO/
WHO, 2002), may have potential benefits in the maintenance
of healthy glucose metabolism. However, despite encouraging
preclinical studies, the clinical research in this field is still
only starting to emerge. In this review no human clinical stud-
ies assessing the effect of probiotic bacteria specifically on
postprandial glycemia were identified. However, a limited
number of clinical studies addressing the effect of probiotics
on related outcomes such as fasting glycemia and insulin resis-
tance were identified.
Some studies have investigated the effect of probiotics on
fasting glycemia. Moroti et al. (2012) reported that consump-
tion of probiotics and fructo-oligosaccharides reduced fasting
glycemia in elderly subjects with T2DM, whereas consump-
tion of a placebo product did not. Similar results on probiotics
were reported by Ejtahed et al. (2011; 2012), but Chang et al.
(2011) and Schaafsma and coworkers (Schaafsma et al., 1998)
did not observe reduced glycemia in their interventions. Probi-
otics combined with dietary counseling have also been sug-
gested to improve glucose regulation during pregnancy
(Laitinen et al., 2009). Probiotics may also regulate glucose
by targeting insulin action; Andreasen et al. (2010) reported an
improvement in insulin sensitivity in diabetic and nondiabetic
volunteers following consumption of probiotics. A bilberry
drink with oatmeal fermented with probiotics has also been
suggested to lead to reduced insulin demand upon glycemic
response (Granfeldt and Bjorck, 2011). In addition to human
studies, several animal studies have yielded promising results
on the efficacy of probiotics in the maintenance of healthy
fasting and postprandial blood glucose levels and related out-
comes (Andersson et al., 2010; Amar et al., 2011a, 2011b;
Chen et al., 2011).
Dietary Protein and Blood Glucose Regulation
High protein diets appear to have beneficial effects on
weight loss, body composition, and certain blood lipids, at
least in the short term (Hession et al., 2009). Satiating effects
of dietary protein, a reduced choice of foods, and an aversion
against dietary fat in the absence of carbohydrates have all
been attributed to better weight loss with high protein diets
(Weickert et al., 2005). Lowering the percent protein of the
diet from 15% to 10% increases total energy intake (Gosby
et al., 2011), further indicating that a higher intake of dietary
protein may help to reduce energy intake. In a recent review, it
is concluded that dietary protein by acting on satiety and
energy expenditure in negative energy balance may prevent
weight cycling effects (Westerterp-Plantenga et al., 2012),
indicating a beneficial role on weight regulation. Furthermore,
a combination of high-protein and low glycemic load foods, in
a hypo-caloric diet, significantly increased insulin sensitivity
and decreased markers of inflammation in overweight and
obese women with polycystic ovary syndrome (Mehrabani
et al., 2012). Insulin resistance following amino acid infusion
has been reported in healthy humans (Tremblay et al., 2005).
One of the mechanisms of protein-induced insulin resistance
appears to be inhibition of glucose uptake through phosphory-
lation of downstream factors of the insulin signaling cascade
by the translation initiation factor serine-kinase-6-1 (S6K1)
(Tremblay et al., 2005). On the other hand, it has been put for-
ward that branched-chain amino acids (BCAA), in particular
leucine, may help to counteract “anabolic” resistance” which
may increase availability of AA for muscle protein synthesis,
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reduce muscle protein breakdown, and enhance glucose dis-
posal to help maintain blood glucose homeostasis in T2DM
(Manders et al., 2012). Recent data on metabolomic profiling
in obese adults have suggested associations between BCAA
and future risk of T2DM (Newgard et al., 2009a, 2009b),
whereas the opposite has been found in youth (Michaliszyn
et al., 2012a, 2012b). In fact in youth increased plasma AA
concentrations were positively associated with b-cell function.
In animal models particularly the intake of BCAA appears to
lead to unfavorable metabolic effects including insulin resis-
tance, although in rodents the background of a high fat diet is
required to promote these negative effects (Newgard, 2012).
Longer term intake of high protein diets in human has been
shown to result in whole-body insulin resistance (Linn et al.,
2000; Weickert et al., 2006), associated with up-regulation of
factors involved in the mammalian-target-of-rapamycin
(mTOR)/S6K1 signaling pathway (Linn et al., 2000; Weickert
et al., 2006), increased stimulation of insulin and glucagon
within the endocrine pancreas, stimulation of gluconeogenesis
(Linn et al., 2000; Weickert et al., 2006), and high glycogen
turnover (Linn et al., 2000; Weickert, 2012). Furthermore,
protein induced deterioration of insulin sensitivity has been
observed in humans under conditions of restricted fat intake
(30% of energy intake), both on whole-body and liver level, as
measured using euglycemic hyperinsulinemic clamps com-
bined with stable isotope techniques (Weickert et al., 2011a,
2011b). Interestingly, the way of protein administration seems
to be of importance, and supplementation of insulin resistant
rats with leucine through gavage, that is intermittent feeding,
significantly lowered fasting glycemia compared with continu-
ous administration through the drinking water (Zanchi et al
2012).
In the short-term, these unfavorable effects on insulin
resistance could be compensated by high protein diet
induced weight loss, and, at least in physically active peo-
ple, an increase of the in lean muscle mass that is also medi-
ated via the mTOR/S6K1 pathway. In the Diet, Obesity and
Genes (DiOGenes) European multicentre trial with 548
completers, maintenance of weight loss was marginally bet-
ter with the high protein diet despite controlled conditions,
with no significant difference between groups in the full
model (Larsen et al., 2010). Furthermore, DiOGenes
revealed that both, a high protein intake or increased intake
of high-GI carbohydrates, may increase low-grade inflam-
mation (G€ogebakan et al., 2011), which could be further
related to worsening of whole-body insulin resistance
(M€ohlig et al., 2006). In further agreement that high pro-
tein-diets may have deleterious effects on glucose metabo-
lism, a recent large prospective cohort with 10-years
follow-up revealed that consuming 5% of energy from ani-
mal protein, but also from total protein at the expense of fat
or carbohydrates increases diabetes risk as much as 30%
(Sluijs et al., 2010). Furthermore, low carbohydrate high
protein diets, used on a regular basis and without consider-
ation of the source of proteins or the nature of carbohydrates
is associated with increased risk of cardiovascular disease
(Lagiou et al., 2012), thereby suggesting a link between
high-protein Western diets, cardiovascular risk and T2DM.
Given these concerns further research is advised before high
protein diets should be routinely introduced as a tool in the
treatment of patients with T2DM or at risk of developing
diabetes. However, in subjects with intact b-cell function
protein/amino acid induced insulin resistance may be com-
pensated by the also observed amino acid mediated increase
in insulin secretion, as discussed in the next paragraph.
Amino Acid Induced Insulin Secretion
In a state of impaired glucose tolerance or T2DM, endoge-
nous insulin secretion shows multiple abnormalities. Secre-
tory defects include an attenuated early insulin secretory
response to glucose, reduced ability of the b-cell to fully
compensate for the degree of whole-body insulin resistance,
impaired glucose sensing ability of the b-cell, and a shift to
the right in the dose-response curve between glucose and
insulin secretion, all of which are indicative of a progressive
insensitivity of the b-cell to glucose (Polonsky et al., 1996).
These defects involve glucose-sensing and signaling path-
ways in the b-cell. Even though insulin secretion in response
to the prevailing glucose concentration may be blunted in
T2DM subjects, insulin secretion in response to other stimuli
remains functional (van Loon et al., 2003). Besides glucose,
amino acids can also act as potent stimuli for the secretion of
insulin from the pancreatic b-cell (Newsholme et al., 2005).
In vitro studies using incubated primary islet cells or b-cell
lines have described strong insulinotropic properties for argi-
nine, leucine, isoleucine, alanine, and phenylalanine (Floyd
et al., 1963; Sener et al., 1981; Pipeleers et al., 1985; Blach-
ier et al., 1989; Malaisse et al., 1991; Schwanstecher et al.,
1998; Lajoix et al., 2001; Xu et al., 2001a, 2001b; Salehi
et al., 2012). The various mechanisms, by which these amino
acids promote and/or enhance insulin secretion from the pan-
creatic b-cell, are diverse and have not yet been fully eluci-
dated (Newsholme et al., 2005). In the presence of glucose,
amino acids like arginine seem to be able to stimulate insulin
secretion by depolarizing the plasma membrane (Blachier
et al., 1989). The latter results in the opening of voltage-acti-
vated Ca2C channels, resulting in the influx of Ca2C, which
triggers insulin exocytosis (Newsholme et al., 2005). Other
amino acids tend to induce their insulinotropic properties by
activating the Ca2C channels, through their cotransport with
NaC (Sener and Malaisse, 2002). Furthermore, similar to glu-
cose-mediated insulin secretion (Dean and Matthews, 1970),
intracellular catabolism of the metabolizable amino acids in
the pancreatic b-cell will increase the intracellular energy
status (ATP/ADP ratio), which closes ATP-sensitive KC
channels, leading to the depolarization of the plasma mem-
brane (Dunne et al., 1990; Brennan et al., 2002; Newsholme
et al., 2005). In addition, leucine-induced insulin secretion is
mediated both through its oxidative decarboxylation, as well
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as its ability to allosterically activate glutamate dehydroge-
nase (Newsholme et al., 2005; Xu et al., 2001a, 2001b). The
latter has also been reported for other amino acids, like phe-
nylalanine (Kofod et al., 1986). A simplified overview on
some of the proposed mechanisms by which amino acids are
likely to stimulate insulin secretion in the pancreatic b-cell is
provided in Fig. 2.
In accordance with the in vitro data on incubated b¡cells,
in vivo studies in humans have shown increased plasma insulin
concentrations following the intravenous infusion of amino
acids in both healthy (Floyd et al., 1966; Floyd et al., 1970)
and T2DM patients subjects (Floyd, 1968). In line with those
findings, nutritional studies in humans already reported the
synergistically stimulating effect of the combined ingestion of
carbohydrate and protein on plasma insulin concentrations in
the 1960s (Rabinowitz et al., 1966; Pallotta and Kennedy,
1968), which were later confirmed in both healthy (Nuttall
et al., 1985) and T2DM subjects (Nuttall et al., 1984; Gannon
et al., 1992; Gannon et al., 1998). A series of studies trying to
define the in vivo insulinotropic potential of the ingestion of
various free amino acids and protein in combination with car-
bohydrate, report a mixture containing a protein (hydrolysate)
with the addition of free leucine to be most potential (van
Loon et al., 2000a, 2000b). The latter was later shown to allow
a —two–four-fold greater increase in postprandial insulin
release in both healthy and T2DM subjects when compared
with the ingestion of carbohydrate only (van Loon et al.,
2003; Manders et al., 2005; Manders et al., 2006a, 2006b;
Manders et al., 2008). Reduction in PPG was observed follow-
ing intake of whey and soy protein with or without supplemen-
tation with amino acids (isoleucine, leucine, lysine, threonine,
and valine) in healthy volunteers. This reduction was mediated
by an early postprandial insulinaemia (PPI) response and cor-
related with presence of plasma GLP-1 (Gunnerud et al.,
2012a, 2012b). Increased plasma amino acid concentrations
was also shown to be positively associated with b-cell function
relative to insulin sensitivity in adolescents (Michaliszyn
et al., 2012a, 2012b).
The insulinotropic properties of amino acids, and leucine
in particular, may be of relevance as a means to stimulate
endogenous insulin release and, as such, to improve post-
prandial glycemic control in T2DM subjects (van Loon et al.,
2003; Manders et al., 2006a, 2006b). In agreement, various
studies have reported lower postprandial glucose concentra-
tions in both healthy, normoglycemic and T2DM subjects
following co-ingestion of protein (concentrate/hydrolysate)
and/or free amino acids (Nuttall et al., 1984; Nuttall et al.,
1985; Gannon et al., 1992; Gannon et al., 1998; Gannon
et al., 2001; Frid et al., 2005). The greater postprandial insu-
lin response following protein and amino acid co-ingestion
has been proven functional, stimulating blood glucose
uptake, and reducing postprandial hyperglycemia in T2DM
subjects (Manders et al., 2005). Co-ingestion of a small
amount of protein hydrolysate and leucine with each main
meal can be applied to improve 24 h glycemic control by
reducing the prevalence of postprandial hyperglycemia
Figure 2 Overview of proposed mechanisms by which glucose and leucine stimulate insulin secretion. GK, glucokinase; PDC, pyruvate dehydrogenase com-
plex; PC, pyruvate carboxylase; TCA, tricarboxylic acid; a-KG, a-ketoglutarate; AT, aminotransferase; BCKDH, branched-chain a-keto-acid dehydryogenase;
GDH, glutamate dehydrogenase; KIC, a-ketoisocaproate. Adopted form van Loon et al; Current opinion in clinical nutrition and metabolic care, 2012, 15: 71–77.
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(Manders et al., 2006a, 2006b) despite a higher energy
intake. Protein and/or amino acid ingestion strongly stimu-
lates postprandial insulin release in both healthy and T2DM
subjects and, as such, can strongly affect postprandial glyce-
mic control. Dietary intervention strategies to improve PPG
should not only consider the glycemic load of a meal, but
should also consider the protein/amino acid content of the
meal.
Dietary Fatty Acids and Blood Glucose Regulation
A significant positive correlation exists between circulating
free fatty acid levels and insulin resistance in tissues. Twenty
years ago, Storlien et al. (1991) reported that high saturated
fat-fed rats developed insulin resistance, whereas those fed
with diets high in n-3, with a low n-6/n-3 ratio, maintained
insulin action at normal levels. Subsequent studies of platelet
membrane phospholipid fatty acid content in Indian Asians
who are at increased risk of metabolic syndrome showed a
greater proportion of n-6 polyunsaturated fatty acid (PUFA)
linoleic acid, and arachidonic acid in combination with a
reduced proportion of the n-3 long chain (LC)-PUFAs, eicosa-
pentanoic acid (EPA), and docosahexaenoic acid (DHA) in
Indian Asians than in whites (Lovegrove et al., 2004). These
effects have variably been attributed to PUFA-mediated altera-
tions of the membrane phospholipid characteristics, such as
fluidity (Rustan et al., 1997) or through the saturated fatty acid
(SAFA)-driven accumulation of ceramide and diacylglycerol,
which inhibit Akt/PKB activation. Latterly, an increase in cer-
amide content in skeletal muscles of obese insulin resistant
humans (Adams et al., 2004) and in subjects who showed
insulin resistance after lipid infusion (Straczkowski et al.,
2004) ends further support to its role, possibly through altera-
tions in lipid raft formation and stability (Xu et al., 2001a,
2001b) or increased reactive oxygen species (ROS) generation
from mitochondrial uncoupling. In vitro experiments have
confirmed that the presence of the monounsaturated fatty acid,
oleate, can divert palmitate away from ceramide synthesis and
prevent ceramide accumulation and insulin resistance (Gao
et al., 2009; Gao et al., 2012). Since dietary fat and the result-
ing plasma fatty acids profiles are corelated, dietary interven-
tion is predicted to influence insulin resistance.
A systematic analysis of the literature for studies reporting
on the impact on blood glucose and insulin of interventions on
fatty acid intake in the diet of adult humans with either obesity
or T2DM has been undertaken here. We have identified 20 rel-
evant studies for inclusion in systematic review, of which 3
considered fatty acid length and degree of esterification (Scalfi
et al., 1991; Li et al., 2008), 4 examined n-3 PUFAs (Zambon
et al., 1992; Brady et al., 2004; West et al. 2005, Madigan
et al., 2000; Jans et al., 2012), 14 investigated effects of cis-
MUFA (Lerman-Garber et al., 1994; Christiansen et al., 1997;
McCargari et al., 1998; Madigan et al., 2000; Thomsen et al.,
2003; Piers et al., 2003; Manning et al., 2004; West et al.,
2005; Lefevre et al., 2005; Paniagua et al., 2007; de Natale
et al., 2009; Sloth et al., 2009; Li et al., 2010; Lopez et al.,
2011; Jans et al., 2012) three considered trans-MUFA (Christi-
ansen et al., 1997; Lefevre et al., 2005; de Natale et al., 2009)
with 7 describing effects of SAFA (Rivellese 1996; Christian-
sen et al., 1997; Thomsen et al., 2003; Piers et al., 2003; Man-
ning et al., 2004; Devaraj et al., 2008; Lopez et al., 2011). In
total, dietary effects on postprandial glucose or insulin were
reported in 689 participants. Key features of these studies are
reported in Table 4. Overall, there was no effect of varying tri-
acylglycerol, diacylglycerol or chain length on insulin resis-
tance in study participants although some benefits for lipid
metabolism were noted. In contrast, closer examination of
PUFA invention studies showed mixed results; one study
reported a decrease in PPI concentration (n D 10, 12 weeks
PUFA intervention) whereas a second reported no benefit (n D
18, US T2DM subjects, single PUFA meal) a third (n D 11,
T2DM subjects in Ireland, two weeks PUFA intervention)
reported higher PPI concentrations after compared with post-
MUFA diets and a fourth reported improved AUC over 6 h for
glucose and insulin after PUFA and MUFA compared to SFA
(n D 10, Dutch insulin resistant, single meal). The variability
in duration of dietary change may be significant in determining
effect, with benefit being observed in the study with longest
intervention. In the two studies that described an investigation
of trans-MUFA, one did not show any significant difference to
MUFA in outcomes and the second showed comparable
effects to a saturated fatty acid diet. This is consistent with a
review by Thompson et al. (2011) that there is very little con-
vincing evidence that habitual exposure to dietary trans-fatty
acid as part of a standard western diet has a significant contri-
bution to risk of diabetes or insulin resistance. However, stud-
ies in FABP2Thr54 carriers (at increased risk for T2DM
complications) have shown increased postprandial glucose fol-
lowing trans-MUFA challenge compared to noncarriers of this
allele (Lefevre et al., 2005). The majority of studies identified
systematically in this present review have described cis-
MUFA interventions on insulin resistance involving 277 sub-
jects in 12 studies. Only 24 subject interventions showed no
significant benefit, with the remaining 10 studies of 253 partic-
ipants describing significant reductions in either postprandial
glucose and/or insulin compared to control diets. Taking the
systematic analysis of dietary fatty acid modulation together
strongly supports the benefit of replacement of fats with
MUFAs in the diet of T2DM or obese insulin-resistant subjects
for the improvement of their glucose/insulin metabolism.
Impact of Micronutrients on Blood Glucose Levels
Dietary Vitamins and Glycemic Control
Micronutrients are nutrients required in small quantities for a
whole range of physiological functions, but which the organism
itself cannot produce. Micronutrients include dietary trace min-
erals, which are generally less than 100 mg day¡1 and vitamins.
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Vitamins, organic molecules that are vital for normal physiol-
ogy in any organism, are known to improve health when sup-
plemented during specific deficiency states. However, less is
known of the clinical value for supplementing to improve the
outcomes of diseases that are associated with lower plasma
vitamin levels. Concerns exist that vitamin supplementation for
health benefit may be distributed according to a bell-shaped
curve, where deficiency contributes to disease but excessive
vitamin intake may also have adverse health outcomes for
some individuals. However, the association between vitamin
E and all cause mortality is now disputed (Gerss, 2009). A num-
ber of clinical trials are registered presently that are investigat-
ing vitamin supplementation in early diabetic states to prevent
onset of T2DM, or in T2DM subjects to improve outcome
measurements such as HbA1c level. A limited number of stud-
ies have completed which describe vitamin effects on PPG or
PPI and these are summarized and discussed.
The complex of B vitamins serves as cofactors principally
associated with metabolism and circulating plasma levels of B
vitamins are reduced in some diabetic populations (Mitri et al.,
2011; Page et al., 2011). Thiamine (vitamin B1) is an essential
coenzyme for the transketolase enzyme and the dehydrogenase
complexes for pyruvate, a-ketoglutarate, and branched-chain
keto acids which is at lower plasma concentration in T2DM
(Page et al., 2011). Benfotiamine, a lipid-soluble allithiamine
derivative that has better intestinal absorption and improved
bioavailability than thiamine, has been shown to afford post-
prandial benefit on vascular function following meals rich in
advanced glycation end-products in T2DM. Plasma glucose
levels were lowered in the benfotiamine supplemented group
but not significantly in the postprandial period after and AGE
meal (Stirban et al., 2006), but the effects of benfiotamine on
PPG were significant after a cooked meat meal (Stirban et al.,
2007). The pharmacologic effects of niacin (nicotinic acid;
vitamin B3) on cholesterol lowering were first reported in
1955 (Altschul et al., 1955). It is potent in lowering fasting tri-
glycerides and postprandial triglycerides, however, extended-
release niacin increased postprandial insulin concentrations by
54% by 2 h after a high-fat meal indicating a decrease in insu-
lin sensitivity (Plaisance et al., 2008). Nevertheless, there
remain some significant benefits of niacin for management of
cardiovascular complications and the most recent summarized
evidence suggests that the cardiovascular benefit outweighs
the reduction in glycemic control (Goldberg and Jacobson,
2008; Bays et al., 2011). However, it was observed that treat-
ment with high dose, extended-release niacin did not reduce
the risk of cardiovascular events (including heart attacks and
stroke) in people with heart and vascular disease receiving
intensive statin therapy (Boden et al., 2011). The cofactor,
biotin (vitamin B7) works in synergy with insulin and indepen-
dently increases the activity of glucokinase. No studies meet-
ing the inclusion criteria for this review were identified using
biotin supplementation alone. However, in moderately obese
subjects with T2DM and with impaired glycemic control sup-
plemented with chromium and biotin combination for four
weeks, glucose levels decreased at 1 h and 2 h and glucose
area under the curve and fructosamine level were significantly
decreased (Geohas et al., 2007).
As a lipid soluble vitamin whose levels are expected to cor-
relate to an extent with lipid levels, the interpretation of the
association that exists between plasma vitamin D and diabetes
is complicated (Muscogiuri et al., 2011). Nevertheless, daily
intake of a vitamin D-fortified yogurt drink (500 IU vitamin
D3), either with or without added calcium, improved glycemic
status in T2DM patients measured as HOMA-IR (Nikooyeh
et al., 2011). In contrast, supplementation with cholecalciferol
did not improve glycemic control in T2DM whose serum 25-
hydroxyvitamin D levels were in the normal range at baseline
(Jorde and Figenschau, 2009). Similarly, non-T2DM subjects
with lower than normal plasma vitamin D levels did not show
any difference in glucose homeostasis post glucose tolerance
test (Tai et al., 2008). Using 2H NMR analysis of monoace-
tone glucose (MAG) after tracer administration to understand
what effect vitamin D3 may have on hepatic glucose metabo-
lism revealed no changes in the percentage contribution of
glycogenolysis (O’Sullivan et al., 2011). At present there is a
lack of evidence to support any intervention with vitamin D
on PPG and this was compounded by the early termination of
the Thiazolidinedione Intervention with vitamin D Evaluation
(TIDE) randomized controlled trial due to concerns over
increased cardiovascular events with rosiglitazone (Punthakee
et al., 2012).
High plasma and cellular nutrients promote the formation
of reactive oxygen species (ROS) from membrane NADPH
oxidase and mitochondria. It has been proposed that ROS play
an important role in insulin resistance and, therefore, vitamins
as dietary antioxidants may act as important mitigants of meta-
bolic stress, promoting glucose and fatty acid utilization. Anti-
oxidants frequently act in concert, at least in vitro, each
operating within defined redox couples and transferring radi-
cals to yield less reactive/damaging products. The principal
dietary antioxidants include a number of vitamins (C-ascor-
bate, E-tocopherols and A-carotenoids) which are essential for
human health, and phytochemicals such as lycopene. Recently,
we have undertaken a meta-analysis and shown that HbA1C
levels were significantly reduced by antioxidant supplementa-
tion, suggesting that antioxidants may have some benefit in
protecting against the complications of T2DM (Akbar et al.,
2011). Our analysis showed that vitamin C or E supplementa-
tion did not affect plasma glucose or insulin levels, and here
we have supplemented these studies by examining the effect
of antioxidant vitamins on postprandial glucose/insulin.
Four studies (Nappo et al., 2002; Carroll and Schade 2003;
Evans et al., 2003; Neri et al., 2005) were identified that met
inclusion criteria for the study investigating antioxidant effects
in 77 subjects with all studies incorporating vitamin C, three
also including vitamin E and one also including N-acetyl cyste-
ine. Summary information is shown in Table 5. Supplement
duration varied from immediately prior to the test fatty meal up
to 14 days of supplementation prior to meal test. None of the
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studies reported any benefit on plasma glucose excursions in
the postprandial period following antioxidant intervention.
More recent interest in vitamin E has been directed toward
gamma tocopherol as the active constituent which is reported
to have anti-inflammatory and gene regulatory effects. Master-
john et al. (2012) have investigated effects of vitamin E supple-
mentation enriched with (500 mg day¡1) gamma tocopherol on
PPG in 12 healthy, normoglycemic, college students. They did
not see any benefit for AUC glucose or insulin following five-
day ingestion of a supplement enriched in g-tocopherol.
Dietary Minerals and Blood Glucose Regulation
Deficiencies of several dietary minerals (such as chromium,
magnesium, and zinc) have been reported in T2DM subjects.
As there is no evidence of beneficial effects of mineral supple-
mentation on diabetic subjects without underlying deficien-
cies, the following review will be focused on the evidence of
three most reported micronutrients on glucose control
(Table 5).
Chromium. Chromium is a trace mineral which plays an
important role in whole body glucose homeostasis by enhanc-
ing the binding of insulin to insulin receptor (Cefalu and Hu,
2004). Beneficial roles of chromium supplementation on glu-
cose metabolism have been demonstrated in T2DM subjects.
For example, chromium supplementation (500 mg/d chro-
mium picolinate) for four-months in T2DM subjects showed a
significant reduction of fasting and postprandial glucose levels
(Anderson et al., 1997; Cheng et al., 1999) and this beneficial
effect existed after chromium supplementation for a 10-month
period. Moreover, an acute chromium supplementation at
400 mg and 800 mg to a white bread meal showed a substan-
tial reduction in PPG in young, apparently healthy adults com-
pared with the white bread meal supplemented with a placebo
(Frauchiger et al., 2004).
Magnesium.Magnesium is a mineral which plays important
roles in glucose transport and, therefore, blood glucose metab-
olism. A reduced plasma magnesium levels has been often
reported in subjects with T2DM. A previous study in young
diabetes subjects in Bangladeshis showed that more than half
the subjects were hypomagnesemic (Khan et al., 1999). Fur-
thermore, a recent cross sectional study showed lowered mean
magnesium intake, urine magnesium, plasma magnesium, and
erythrocyte magnesium in T2DM subjects with poor glucose
control (Sales et al., 2011). However, because the lack of ran-
domized interventional studies, the role of magnesium in
hyperglycemia in T2DM subjects is not clear and future stud-
ies are required.
Zinc. Zinc is a mineral that plays important roles in the syn-
thesis and insulin sensitivity (Roth and Kirchgessner, 1981;
Park et al., 1986; Brun et al., 1995). Previous studies have
shown that plasma and tissue zinc concentrations in humans
and animal models with T2DM are lower than in nondiabetic
subjects due to the increased urinary zinc excretion by uncon-
trolled diabetes (Kinlaw et al., 1983). Supplementation of zinc
is found to be beneficial in alleviating the hyperglycemia of
ob/ob and streptozotocin-induced diabetic mice models (Chan
et al., 1998; Chen et al., 2000). Also, a randomized study eval-
uated the effect of zinc with other antioxidants on blood glu-
cose in human diabetic subjects on long-term follow-up. They
showed that oral zinc sulfate (22 mg/day) supplementation
with a multivitamin/mineral preparation (vitamin A, vitamin
D3, vitamin E, magnesium, manganese, copper, and selenium)
for a four-month period significantly reduced both fasting and
postprandial glucose levels in previously diagnosed (for at
least two years) subjects from Sri Lanka with T2DM compared
to the placebo group (Gunasekara et al., 2011). Another study
in ob/ob mice also showed that administration (by gavage) of
arachidonic acid plus zinc significantly increased glucose dis-
posal in ob/ob mice and effectively decreased blood glucose
levels in obese mice from acute treatment (30 min; 3 h) to up
to 14 days prolonged treatment (Hwang et al., 2002). Further
human studies are required to fully evaluate the effect of zinc
supplementation alone on glucose metabolism in diabetic
subjects.
Impact of Phytochemicals on Blood Glucose Regulation
Phytochemicals are plant secondary metabolites broadly
classified according to the pathway from which they are
derived. Very few studies have directly attributed specific
phytochemicals as to having an effect on PPG. Much of the
data discussed concern the observation that a phytochemical-
rich food has been effective in modulating the glycemic
response and the foods include: berries, nuts, soy, cinnamon,
seaweed, tea, ginseng, beans, chocolate, and the herbal
extract ‘`salacia’’ (Tables 6–8). The phytochemicals associ-
ated with fiber are an important and likely effective group
and this has been discussed above. The most widely studied
phytochemical rich foods studied for their effect on postpran-
dial metabolism are berries, nuts, cocoa, and beverages (tea
and coffee). This is due to their strong epidemiological asso-
ciation of these products with cardiovascular health.
The compounds that appear to be of particular importance
are phenylpropanoid-derived and comprise predominantly the
flavonoids and phenolic acids (Table 6). Many preclinical and
in vitro studies have shown these molecules can attenuate the
postprandial glycemic response, improve acute insulin secre-
tion, and insulin sensitivity and these have been extensively
reviewed (Hanhineva et al., 2012). No human studies to date
have demonstrated a direct effect of the flavonoids or phenolic
acids on PPG. However, resveratrol, a phenylpropanoid-
derived stilbene found in grape skins has been shown to reduce
plasma glucose and improve insulin resistance in volunteers
with T2DM, when administered in a capsule (Brasnyo et al.,
2011). The seed extract of grapes also had an effect on blood
glucose regulation by lowering fructosamine in T2DM volun-
teers (Kar et al., 2009). In this study, an improvement in
endothelial function, antioxidant status, and C-reactive
DIET AND BLOOD GLUCOSE REGULATION 573
protein (CRP) was described. Other soft fruits found to
decrease plasma glucose levels were fig (Serraclara et al.,
1998), sea buckthorn berries (Lehtonen et al., 2010), and
mixed puree containing blackcurrant, bilberry, cranberry,
and strawberry (Torronen et al., 2010). Again, no direct
effect of an individual phytochemical could be attributed.
Few human studies have explored vegetables as a potential
source of phytochemicals which could effect PPG. A Flaxi-
nius species extract was found to have an acute effect post-
prandial glucose levels in healthy male volunteers (Visen
et al., 2009). Another particularly phytochemical rich plant
source found to effect PPG in healthy volunteers was sea-
weed (Goni et al., 2000). Seaweed is also a rich source of
vitamins, minerals, and amino acids, and the causative
effect needs further investigation.
Of the foods containing these phytochemicals, flavan-3-ol
rich chocolate and tea are widely studied. In healthy and IGT
volunteers (with no symptoms of diabetes) chocolate had an
effect on blood glucose levels when in response to an OGTT
(Grassi et al., 2005, 2008), although no effect was observed on
insulin sensitivity measured by the glucose clamp method in
mild-moderate hypertensive volunteers (Muniyappa et al.,
2008). Tea is the second most commonly consumed beverage
worldwide after water (Table 8). Results of epidemiological
studies have suggested that consumption of tea (mainly green
tea) could lower the risk of T2DM (Iso et al., 2006) as well as
cardiovascular risk through decrease of CRP (Steptoe et al.,
2007; Rebello et al., 2011), serum amyloid A and haptoglobin
(De Bacquer et al., 2006). Maki and coauthors did not confirm
the link between tea consumption and CRP, but daily users of
green tea represented more than 80% of the sample, and they
others were potentially coffee drinkers (Maki et al., 2010). So,
it is difficult to see the clear link with CRP in a population
where tea and coffee are consumed daily. Animal studies
showed a clear effect of green tea extracts on the improvement
of glucose tolerance either in induced diabetic rats or in
genetic models of rodents with T2DM (Sae-tan et al., 2011).
Despite preclinical evidence (Tsuneki et al., 2004), green tea,
when consumed as a beverage had no effect on postprandial
glucose or insulin response when consumed within a meal or
one hour prior to a meal in healthy human volunteers (Louie
et al., 2008; Josic et al., 2010). Green tea has been particularly
studied for health interest because of its high content on poly-
phenolic compounds (especially catechins). Consumption of
an epigallocatechin gallate (EGCG; > 97%) enriched extract
by overweight volunteers also showed no change in glucose
levels, insulin sensitivity or secretion (Brown et al., 2009).
However, there was some correlation of green-tea phenolic
intake and insulin levels in healthy humans (Fukino et al.,
2005) and a catechin-rich green tea increased insulin levels in
volunteers with T2DM subjects (Nagao et al., 2009). Another
cross-sectional study linked green tea consumption to the low-
ering of fasting blood glucose and fructosamine (Maruyama
et al., 2009). In a longer term study it was demonstrated that
daily supplementation of green tea-extract powder (as an
equivalent of 456 mg of catechins daily) for two months low-
ered the HbA1c levels in subjects with borderline diabetes
(Fukino et al., 2008) and green tea was inversely associated
with plasma C-reactive protein concentrations (Rebello et al.,
2011). Some potential mechanism of action of the catechins
could be the modulation of certain glucose metabolism
enzymes in the liver (increase of glucokinase expression and
decrease phosphoenolpyruvate carboxykinase), as well as lipid
metabolism enzymes in the liver and adipose tissue (acyl-CoA
oxidase-1 and carnitinepalmitoyl transferase-1), and poten-
tially on some adipose and muscle glucose receptors (GLUT-4
mRNA or translocation) (Sae-tan et al., 2011). Other types of
tea are less well studied (i.e., dark tea, Oolong tea). However,
it was observed that black tea exhibited a late phase plasma
glucose response in healthy humans with a corresponding
increase in insulin (Bryans et al., 2007). In conclusion, contro-
versial results have been obtained on the consumption of tea
and its impact on glucose metabolism. Discrepancy of results
may be due to type of tea. However, the interest of phenolic
compounds present in green tea seems to be associated with a
positive impact of glucose metabolism.
Coffee is among the most widely consumed beverages in
the world (Table 8). Knowledge on both the positive and
negative health effects of coffee has been shown and it has
been extensively studied in relation to various diseases (Van
Dam and Hu, 2005). Several systematic reviews associated
the habitual consumption of caffeinated or decaffeinated
coffee with a substantially lower risk in T2DM (Van Dam
and Hu, 2005; Tunnicliffe et al., 2008; Floegel et al., 2012).
Higher consumption of coffee was consistently associated
with a lower prevalence of newly detected hyperglycemia,
particularly postprandial hyperglycemia (Van Dam and Hu,
2005). Some interesting additional inverse associations were
found between coffee consumption and inflammatory
markers; CRP, Tumor Necrosis Factor alpha (TNF-a) (Wil-
liams et al., 2008; Maki et al., 2010) and some interleukins
(Wedick et al., 2011). The potential beneficial chronic
effects of coffee may be related to antioxidant compounds
including chlorogenic acid (Johnston et al., 2003; van Dam
2006; Tunniclifeet and Shearer, 2008). However, no direct
link has been established so far. The acute effect of coffee
may be different if consumed within a meal or before the
meal, and if it is decaffeinated or caffeinated coffee. It has
been shown that caffeinated coffee elicited acute insulin
insensitivity when ingested around one hour before a carbo-
hydrate meal compared to decaffeinated coffee (Moisey
et al., 2008). Additionally, co-ingestion of caffeinated cof-
fee with a high carbohydrate meal increased the blood glu-
cose response, without modifying postprandial insulin
response. Three hours later, an OGTT showed decreased
insulin sensitivity after the caffeinated coffee compared to
water of decaffeinated coffee (Moisey et al., 2010). Based
on the current knowledge, the controversy between deleteri-
ous acute effect and beneficial chronic effect of caffeinated
coffee has not been clarified. However, decaffeinated coffee
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could be another alternative to provide a beneficial impact
on the glycemic response.
Nuts in general contain very little available carbohydrate
and, therefore, contribute little to the postprandial glycemic
response. Addition of nuts (almonds, pistachios, and mixed
nuts) to carbohydrate rich foods has been shown to blunt
the glycemic response (Jenkins et al., 2006) in a dose
dependent manner (Josse et al., 2007; Kendall et al.,
2011a, 2011b) up to 55% (90 g) in healthy people
(Table 8). Also, in T2DM subjects, mixed nut intake
decreased the PPG response dose dependently, although
the effect was half of the effect seen in nondiabetic sub-
jects (Kendall et al., 2011a). In another study in T2DM
subjects ingestion of 28 g almonds before a high-starch
meal lowered PPG by 30%, but did not demonstrate this
response in healthy volunteers. In contrast to the former
studies, in this study, the control meal contained added fat
(butter), and the amount of butter was reduced to compen-
sate for the fat content of the almonds in the treatment
meal. In impaired glucose tolerant adults, incorporation of
whole almonds into a breakfast meal containing 75 g of
carbohydrate also resulted in a lower PPG response and
blunted the glucose levels throughout the day. The mecha-
nism of action of nuts on PPG may be due to a reduction
in gastric emptying rate as a consequence of the additional
energy from fat and protein. However, when the energy
and fat contents of meals were controlled, a reduction in
PPG was observed (Cohen and Johnston, 2011). Alterna-
tively, the phytochemicals in nuts (phytates and phenolics)
could play a role by reducing amylase activity, the enzyme
that hydrolyzes starch. Addition of nuts to meals resulted
in decreased (Jenkins et al., 2006) (healthy volunteers) or
unchanged (Cohen and Johnston, 2011; Mori et al., 2011)
(IGT, DM2) insulin response and increased insulin levels
after a second meal (Mori et al., 2011) (IGT). Furthermore,
addition of nuts to a meal may result in less oxidative pro-
tein damage (Jenkins et al., 2006). Only a limited number
of longer term trials with nuts on glycemic control have
been conducted in people with T2DM. Three relatively
small and short-term studies have generally not found sig-
nificant improvements in markers of glycemic control with
nut consumption (for overview, see, Kendall et al., 2010).
However, a recent pilot trial in which ingestion of one
serving of almonds 5 days week¡1 resulted in a 4% reduc-
tion of HbA1c (Cohen and Johnston, 2011). In addition a
very recent well-powered study of 117 subjects with
T2DM, consumption of mixed nuts (73 g/d) for 12 weeks
significantly reduced HbA1c levels and improved blood
lipid risk factors for CHD (Jenkins et al., 2011). Although,
no compounds could be individually attributed to the
effects observed, nuts are rich sources of phenolics and
phytosterols, as well as macro- (e.g., MUFA) and micronu-
trients (e.g., a-tocopherol). More studies are required to
make definite conclusions on the role of nuts in glycemic
control.
With reference to more specific phytochemicals, various
herbal extracts have been shown to be effective. This includes
Ginseng, both Asian (Panax ginseng) and American (Panax
quinquefolius) and Korean Red (Panax ginseng; heat treated)
species (Table 8). The two most popular types of ginseng,
namely Panax quinquefolius L (American ginseng) and Panax
ginseng CA Meyer (Asian ginseng) are most widely studied
with respect to their hypoglycemic effects. In a series of ran-
domized, placebo controlled studies, American ginseng has
been shown to reduce PPG by up to 39% in healthy volunteers
(Vuksan et al., 2000a, 2000b; Vuksan et al., 2001; Dascalu
et al., 2007) and up to 22% in T2DM subjects (Vuksan et al.,
2000a; Vuksan et al., 2000c). In one study with healthy volun-
teers, only a trend for hypoglycemic effects was found and one
study did not find any effects of American ginseng on PPG
(Sievenpiper et al., 2003a). The effects of Asian ginseng are
mixed, with some studies showing increasing (Sievenpiper
et al., 2003a), no (Sievenpiper et al., 2003a, 2003b; Reay
et al., 2006; Reay et al., 2009) or decreasing effects up to 29%
(Sievenpiper et al., 2006; De Souza et al., 2011) on indices of
PPG in healthy volunteers. The high variability in efficacy on
PPG may be secondary to the variability in the ginseng source
(species, batch, preparation, part of the plant, and variety) and
its composition, as represented by the measured ginsenoside
profile. For example, Korean red ginseng rootlets have been
shown to decrease PPG (Vuksan et al., 2008), while the root
body has not (Sievenpiper et al., 2006; De Souza et al., 2011).
This inconsistency limits the generalizability of the effects
from one ginseng source to another and thereby, the use of gin-
seng as a hypoglycemic agent by subjects with T2DM. How-
ever, it has been shown in a so called “acute to chronic testing
model” that an acute clinical postprandial model used to select
the most efficacious ginsenoside profile, dose, and time of
administration is able to identify sources of ginseng with
safety and efficacy on long term glycemic parameters in
T2DM subjects (Vuksan et al., 2000d; Vuksan et al., 2003).
Two other long-term studies in T2DM subjects, with some
(methodological) limitations, also showed positive effects of
ginseng on glycemic control (Sotaniemi et al., 1995). In 18
healthy volunteers (placebo controlled, double-blind, cross
over study), 200 mg Panax ginseng extract during eight weeks
had no effect on any gluco-regulatory parameter investigated.
(Reay et al., 2009) The mechanism behind the hypoglycemic
effects of ginseng are unknown but may include modulation of
digestion of food and thereby carbohydrate absorption. Modu-
lation of glucose transport and insulin secretion have also been
proposed (Vuksan et al., 2000a). It is hypothesized that the
ginsenosides may be responsible for the effect, but phyto-
chemicals such as the alkaloids or other plant components
may be involved. There have also been various studies on cin-
namon with no conclusive results. A recent study where a cin-
namon extract was administered to healthy volunteers had no
effect on PPG (Markey et al., 2011). However, several human
studies with the herbal extract of Salacia oblonga have demon-
strated significant decreases in postprandial glucose levels in
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both healthy and T2DM subjects (Collene et al., 2005; Hea-
cock et al., 2004; Williams et al., 2007). The mechanism of
action is considered to be through competitive inhibition of
a-glucosidase activity and two bioactive phytochemicals kota-
lanol and salacinol have been isolated (Matsuda et al., 2005).
The mechanism of action of nonnutrients on PPG is mostly
unknown due to poor classification of the phytochemical com-
position of the foods studied. Potential mechanisms are mostly
based on in vitro, preclinical and human ex vivo data. Some
general mechanisms that have been proposed include: inhibi-
tion/retardation of carbohydrate digestion, modulation of glu-
cose release, uptake and absorption, stimulation of insulin
secretion (pancreatic b-cells), activation of receptors, modula-
tion of signaling/gene expression, inhibition of lipolysis,
decrease in oxidative stress and inflammation. It may be that
the level required of certain plant products may be too high to
tolerate. For example, some interventions have been shown to
be ineffective at sustainable product levels (Josic et al., 2010;
Clegg et al., 2011) and the food may have to be provided as a
purified extract. For this reason, herbs, spices, and certain plant
extracts (with high phytochemical content) are likely to be
more effective. There is also little consideration regarding the
phytochemicals associated with fiber and protein rich plants
such as cereal crops and soya. Phytochemicals bound to these
fractions can be released within the gastrointestinal tract and
influence PPG, but few studies address their metabolism and
bioavailability. It is clear that phytochemical-rich foods have
potential to influence PPG, but in order to understand the
impact of individual components on glucose metabolism it
will be essential that the bioactive metabolites are identified.
Impact of Miscellaneous Food Components on Blood
Glucose Regulation
Low-calorie Sweeteners and Glycemic Response
People with diabetes need to monitor their carbohydrate
intake in order to control blood glucose levels. Low-calorie
sweeteners are added to foods, beverages, and used as table-
top sweeteners to provide sweetness without the calories or
carbohydrates. As a caloric sweetener replacement, they are
added in smaller quantities; hence, they provide few or zero
calories. Low-calorie sweeteners do not affect the glycemic
response and can help control overall carbohydrate intake by
substituting for higher energy yielding sweeteners (Duffy and
Sigman-Grant, 2004; Fitch and Keim, 2012).
A recent review (Fernstrom et al., 2012) concluded that
ingestion of low-calorie sweeteners by animals and humans
does not cause the hypothesized changes in blood glucose or
hormone levels. An animal study observed that rats given ace-
sulfame-K saccharin, stevia or sucralose by gavage showed no
change in blood concentrations of GLP-1, GIP, and glucose.
Also, low-calorie sweeteners by gavage did not influence the
rise in blood glucose during an oral glucose tolerance test
(Fujita et al., 2009). The influence of drinking solutions con-
taining acesulfame-K (165 mg), aspartame (165 mg), cycla-
mate (800 mg) or saccharin (75 mg) on blood insulin and
glucose levels in human volunteers over the following 2 h in
comparison with sucrose (30 g) or water controls was investi-
gated (H€artel et al., 1993). In comparison with the water con-
trol, and in contrast to the dose of sucrose, it was concluded
that the ingestion of acesulfame-K, aspartame, cyclamate or
saccharin (at moderate doses) did not increase blood glucose
and insulin over the 2-h study period.
Further information is available from clinical research on
the more recently developed sweeteners such as sucralose and
stevioside/rebaudioside A (commonly known as stevia). A
high single oral dose of sucralose (1000 mg) given orally to
individuals with noninsulin-dependent diabetes mellitus and
individuals with insulin-dependent diabetes did not influence
plasma C-peptide or glucose concentrations (Mezitis et al.,
1996). A single oral dose of sucralose (10 mg/kg) did not
affect the glucose-induced changes in blood glucose levels
when given with a large test dose of sucrose (100 g) (Roberts,
1999). Furthermore, a randomized, double-blind, placebo-con-
trolled study in which 128 subjects with T2DM were given
either sucralose (667 mg/d for 13 weeks) or placebo showed
no effect on fasting plasma glucose, HbA1c or fasting serum
C-peptide, demonstrating no effect of chronic ingestion of
sucralose on glucose homeostasis (Grotz et al., 2003). A simi-
lar effect was observed when the low calorie sweetener, ste-
vioside/rebaudioside A was consumed in a chronic study by
patients with diabetes (Maki et al., 2008).
In summary, the above randomized human studies that var-
ied from 1 to 16 weeks in duration found no significant differ-
ence between the effects of low-calorie sweeteners and
various comparisons (sucrose, starch or placebo) on standard
measures of glycemic and in general did not detect clinically
relevant effects (Table 9). Furthermore, in the last two years
more data have emerged. Anton and colleagues (2010) looked
at the effects of preloads containing stevia, aspartame, and
sucrose on food intake, satiety, and postprandial glucose and
insulin levels in both lean and obese individuals. They con-
cluded that stevia preloads reduced postprandial blood glucose
and insulin levels, suggesting stevia may assist with glucose
regulation. Raben et al. (2011) looked at importance of
exchanging sucrose for sweeteners, on risk factors for diabetes
development. Healthy overweight subjects were randomized
to consume drinks and foods sweetened with either sucrose or
sweeteners as supplements to their usual diet. After 10 weeks,
a diet rich in low-calorie sweeteners had no effect on postpran-
dial glucose, insulinemia, and lipidemia. Lastly, a study by
Brown (2012) concluded that drinking diet soda could increase
the amounts of a hormone that has been previously shown to
be beneficial for people with diabetes when it comes to appe-
tite and insulin secretion. More research, however, is needed
to determine if this finding may impact future treatment of
individuals with diabetes (Brown et al., 2012). In conclusion,
the use of low-calorie sweeteners and the products that contain
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them by subjects, with or without diabetes, do not affect blood
glucose and are tools to help people reduce and control their
caloric intake. Reducing calories could help to attain and
maintain a healthy body weight, and thereby lower the risk of
heart disease and diabetes. Leading health groups such as
American Heart Association, American Diabetes Association
(Gardner et al., 2012), and the Academy of Nutrition and Die-
tetics (Fitch and Keim, 2012) also agree that substituting low-
calorie sweeteners for added sugars in beverages and other
foods has the potential to help people reach and maintain a
healthy body weight and help people with diabetes with glu-
cose control.
Water and Glycemic Control
Addition of water to a test meal resulted in a 40% increased
glucose response in 12 well controlled T2DM subjects
(Table 9). In poorly controlled diabetic subjects, however, no
significant effect was found, probably due to the varying fast-
ing glycemia in these subjects (Torsdottir and Andersson,
2009). In another study in T2DM subjects, similar glucose
responses were found to test meals with either 90 or 600 mL
of tap water (Gregersen et al., 1990).
Alcohol and Glycemic Control
Epidemiological studies showed a U-shaped relationship
between alcohol consumption and T2DM in western countries
(Carlsson et al., 2005), showing that moderate alcohol con-
sumption is associated with an increase in insulin sensitivity
(Facchini et al., 1994; Kiechl et al., 1996; Kroenke et al.,
2003). However, it is also suggested that unhealthy diets which
include alcohol consumption are associated to metabolic dis-
ease genesis. Alcohol consumption of 10 g was associated
with an increase in Low-Density Lipoprotein (LDL) oxidation,
which is implicated in the development of cardiovascular dis-
ease (Schroder et al., 2006). Some inconsistent results may be
attributed to the difference in beverage types, drinking fre-
quency, and other dietary factors. The specific interest of phy-
tochemical content in some alcoholic beverages such as wine
has been addressed above. In a recent prospective cohort
study, moderate alcohol consumption from 0 to 11 g/day of
ethanol as beer, wine or liquors has been studied in around
3000 postmenopausal women with T2DM (Rajpathak et al.,
2010). It was found that an inverse association between quan-
tity and frequency of alcohol intake in relation to incident
CHD (Rajpathak et al., 2010), was consistent with previous
results obtained with nondiabetic postmenopausal women
(Joosten et al., 2008). In an acute setting, moderate alcohol
consumption (around 20 g of alcohol) may decrease the glyce-
mic response when consumed within the meal, or before the
meal (around 2 h prior to ingestion), independently of the type
of beverage (Brand-Miller et al., 2007). However, the con-
sumption of moderate alcohol may not modify the glycemic
response of the breakfast when consumed during dinner (God-
ley et al., 2009). One potential mechanism of action is the
inhibition of the gluconeogenesis and the decrease of glucose
output from the liver, as well as potential inhibition of a-amy-
lase and a-glucosidase. However, this transitory impact of
alcohol on glycemia seems to produce deleterious metabolic
and hormonal consequence in the long term. Animal studies
showed that chronic alcohol consumption increased plasma
glucose and serum leptin, resistin, and adiponectin which are
involved in insulin resistance genesis (Pravdova et al., 2009).
Thus, moderate alcohol consumption may have some meta-
bolic interest, including improvement of insulin sensitivity,
and the reduction of some cardiovascular risk factors, but
some critical questions are pending regarding the potential
beneficial quantity, and which type of alcohol.
Vinegar/Acetic Acid and Glycemic Control
The interest on the effects of vinegar on the glycemic
response has been studied because of the organic acid content,
mainly acetic acid. Several years ago, organic acids such as
acetic and propionic acids were shown to lower the glucose
and insulin responses when added to white bread meals in
healthy subjects (Liljeberg and Bjorck, 1998; Darwiche et al.,
2001; €Ostman et al., 2005). More recently, addition of vinegar
in a carbohydrate rich meal decreased significantly the glyce-
mic and insulin responses in T2DM subjects only after a high
GI meal (Liatis et al., 2010). The blood glucose and insulin
kinetics were not modified after the low GI meal. A recent
paper did not confirm the decrease of glucose response in a
sucrose supplemented rice meal with addition of acetic acid
(Mettler et al., 2009). Although, the authors could not find a
clear explanation to justify this result, it may be due to the ele-
vation of glycemia with rice was not large enough to observe
the decremental effect of acetic acid, as some rice have a low
GI. The potential mechanism of action proposed for acetic
acid to decrease postprandial glucose and insulin responses is
by slowing down the gastric emptying phase (Liljeberg and
Bjorck, 1998; Darwiche et al., 2001), but this was not con-
firmed (Hlebowicz et al., 2008). Thus, addition of vinegar or
acetic acid in carbohydrate rich meal may have a short-term
positive impact by decreasing the postprandial glucose and
insulin responses of high GI meals. There is no information
regarding this addition in longer term studies.
DISCUSSION
Lifestyle modifications with the highest impact on the risk
of diabetes and on blood glucose regulation in the long term
are weight reduction and increased habitual physical activity.
As for diet composition, the strongest correlation of a dietary
component with reduced risk of developing T2DM is with
insoluble and moderately fermentable cereal-based fiber (Hu
et al., 2001; Schulze et al., 2007). Diets rich in fruit and vege-
tables, which are a good source of soluble/fermentable fiber,
have also shown a protective effect. However, the evidence is
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less consistent, particularly if their impact on the risk of T2DM
is evaluated independently of their effects on body weight
(Cooper et al., 2012). Many studies utilize soluble fiber in the
context of a healthy diet and these have been shown to poten-
tially play a role in managing daily glucose levels both in
healthy individuals and individuals with impaired glucose
metabolism. An additional factor, which appears to influence
glycemic and insulinemic responses in addition to the amount
of fiber in the diet, is the food matrix of carbohydrate rich
foods. In particular, soluble fiber has been shown to alter the
physical food form, structure, and viscosity of test foods
(Tappy et al., 1996; Kim et al., 2009), impacting on the rate of
carbohydrate digestion and absorption, which, in turn, is
reflected in the postprandial glucose and insulin responses
(Juvonen et al., 2011; Karhunen et al., 2010). The overall gly-
cemic impact of foods may be markedly affected by the indi-
vidual meal components. However, when single foods were
ranked in relation to their glycemic index, they showed a simi-
lar ranking of blood glucose responses when included in a
mixed meal (Robert and Ismail 2012). In general, the results
suggest that carbohydrate foods that promote low but sustained
blood glucose levels may be considered advantageous with
regard to metabolic control of diabetes (J€arvi et al., 1999),
with acute consumption of foods rich in soluble fiber being
beneficial for both postprandial glycemic control and the insu-
linemic response.
Despite encouraging preclinical studies demonstrating that
control of glycemia is likely to involve interaction with gut
microbes, evidence from human clinical studies is only just
starting to emerge. There are some positive effects of includ-
ing prebiotics in the habitual diet and a limited number of clin-
ical studies addressing the effect of probiotics on related
outcomes such as fasting glycemia and insulin resistance were
identified. Amino acids function as nutritional signals regulat-
ing various metabolic processes and can stimulate secretion of
insulin from the pancreatic b-cells (Newsholme et al., 2005),
with intravenous infusion of amino acids resulting in increased
plasma insulin concentrations (Floyd et al., 1966; Floyd et al.,
1968; Floyd et al., 1970). In particular, leucine can strongly
stimulate endogenous insulin release and has potential to
improve postprandial glycemic control (van Loon et al., 2003;
Manders et al., 2006a, 2006b). Protein and/or amino acid co-
ingestion can improve PPG (Nuttall et al., 1984; Nuttall et al.,
1985; Gannon et al., 1992; Gannon et al., 1998; Gannon et al.,
2001). However, it should be noted that longer term intake of
high protein diets has been shown to result in whole-body
insulin resistance (Linn et al., 2000; Weickert et al., 2006).
Although these unfavorable effects on insulin resistance could
be compensated in the short term by high protein diet induced
weight loss, anabolic effects resulting in increased lean/muscle
mass, and an amino acid induced increase in insulin secretion
in subjects with intact b-cell function, a clearer understanding
of the impact of protein consumption on blood glucose levels
is required. High fat diets are associated with reduced insulin
sensitivity, whereas with lower fat intake the impact appears
to be dependent on the fatty acid composition. The data
regarding dietary fatty acid modulation strongly supports the
benefit of replacement of saturated fats with MUFAs in the
diet of T2DM or obese insulin-resistant subjects for the reduc-
tion of insulin resistance and improvement of blood glucose
levels.
Data regarding the impact of micronutrients on blood glu-
cose regulation is beginning to emerge. Although, there is cur-
rently no data supporting the effect of vitamins on blood
glucose levels it has been shown that plasma concentrations of
B vitamins are reduced in some diabetic populations (Mitri
et al., 2011; Page et al., 2011) and that regular vitamin D
intake improved glycemic control in T2DM subjects
(Nikooyeh et al., 2011). Reduced circulating levels of miner-
als such as magnesium and zinc have been observed in T2DM
subjects (Kinlaw et al., 1983) and there is some evidence that
mineral supplementation can be effective in improving glu-
cose metabolism (Anderson et al., 1997; Cheng et al., 1999;
Gunasekara et al., 2011). However, intervention data from
human studies are severely limited. There is a large and
increasing body of evidence to suggest that phytochemical-
rich foods can improve glucose metabolism. Unfortunately, in
general these studies suffer from poor characterization of the
phytochemical composition of the foods studied and limited
human interventions with single compounds and this
decreased the strength of the data obtained.
Based on the evidence presented in this review, it is clear
that dietary components can modulate blood glucose levels.
Although closely related, fasting and postprandial blood glu-
cose levels are regulated by mechanisms that are to some
extent, different. In fact, while postprandial blood glucose con-
centrations are largely dependent on meal composition, fasting
values are only minimally influenced by the amount and/or
rate of glucose absorption during the previous meal, and reflect
the rate of glucose production in the liver (the two key pro-
cesses being glycogenolysis and gluconeogenesis). Among the
various dietary constituents, the one with the strongest influ-
ence on blood glucose levels in the postprandial period is the
amount of digestible carbohydrate in the diet. Digestible car-
bohydrates include monosaccharides (glucose, fructose), dis-
accharides (sucrose, lactose) and certain polysaccharides
(starch), which are digested and absorbed in the human intes-
tine, thus contributing to the glucose in flow to the blood
stream. However, the impact of dietary carbohydrates on glu-
cose metabolism depends not only on the amount consumed,
as believed in the past, but also on some specific food proper-
ties which can profoundly influence the metabolic effects.
Among these, also the food structure and some specific phys-
ico-chemical characteristics of carbohydrates present in the
food can have a relevant role in modulating blood glucose
response. The ratio between mono-, di- and polysaccharides is
no longer regarded as important in relation to the effects on
postprandial blood glucose since amylase and disaccharidase
activities in the human duodenum are sufficient to hydrolyse
starch and disaccharides within minutes. The meal content of
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protein and fat, although able to influence postprandial glucose
values, has limited practical significance because the magni-
tude of these effects is rather small.
More important are all dietary factors able to delay the
process of digestion and/or absorption of carbohydrates in
the intestine, thus reducing the glycemic response to carbo-
hydrate-rich food. Although, the overall mechanisms of
action are not yet clear, the nature of the effective dietary
components suggests that they are likely to include delayed
gastric emptying and accessibility of the available carbohy-
drates (Thomas and Pfeiffer, 2012). As already mentioned,
soluble viscous types of fiber are those with the largest
impact on the postprandial glucose and insulin response
after a meal. The knowledge of nutritional factors influenc-
ing blood glucose metabolism in the fasting state is still not
complete. Liver glucose production, the major determinant
of fasting glucose levels, is under the control of insulin and,
therefore, not adequately suppressed when insulin resistance
is present; thus nutritional factors influencing fasting plasma
glucose concentrations are primarily those acting on insulin
resistance. The strongest corroboration of efficacy for die-
tary components improving glucose metabolism in the fast-
ing state is available for nondigestible carbohydrates (i.e.,
dietary fiber, resistant starch and fructo-oligosaccarides) and
MUFAs (as replacement of saturated fat) with weaker but
substantial evidence that certain phytochemicals, predomi-
nantly phenolic compounds are likely to be effective. Non-
digestible carbohydrates escape digestion in the small
intestine and are fermented by colonic bacteria in the large
bowel generating SCFAs and other metabolites such as phe-
nolic compounds (Lappi et al., in press; Vitaglione et al.,
2008). This may explain the available, albeit mostly preclin-
ical evidence that suggests that the gut microbiota plays an
important role in metabolic regulation of glucose metabo-
lism. These metabolites could influence liver glucose pro-
duction and, thus, the fasting glucose concentration.
Moreover, they act as prebiotics influencing the composition
of gut microbiota. Finally, alcohol intake also has signifi-
cant, clinical effects on plasma glucose levels. In fact, alco-
hol acutely suppresses hepatic glucose production thus
lowering plasma glucose levels. Conversely, if habitually
consumed in large amounts it impairs insulin sensitivity,
thus deteriorating glucose tolerance and increasing plasma
glucose levels.
In conclusion, T2DM is a lifestyle illness that can be
managed and prevented by reducing excess body weight,
increasing physical exercise and modifying diet composi-
tion as outlined in this review. Intensive interventions
should be undertaken in individuals at high risk and, in
particular, in those with impaired blood glucose regulation,
in whom they have proven to be effective. This is espe-
cially desirable since high blood glucose levels, even if
they are below the diagnostic threshold for diabetes, are
also linked with a high risk for CVD. Therefore, lifestyle
measures effective in improving blood glucose regulation
are useful for prevention of cardiovascular disease as well
as of T2DM. New emphasis on prevention might limit the
dramatic worldwide increase in the incidence of T2DM
expected in the next decades which is also going to impact
on health and longevity of the population.
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ABBREVIATIONS
PPG D Postprandial glycemia
PPI D Postprandial insulinaemia
T2DM D Type 2 diabetes mellitus
GI D Glycemic index
GL D Glycemic load
GP D Glycemic profile
DF D Dietary fiber
HSH D Hydrogenated starch hydrolysates
RS D Resistant starch
SFA D Saturated fatty acid
PUFA D Polyunsaturated fatty acid
MUFA D Monounsaturated fatty acid
TFA D Trans fatty acid
EPA D Eicosapentaenoic acid
DHA D Docosahexaenoic acid
GG D Guar gum
SCFA D Short chain fatty acid
IGT D Impaired glucose tolerance
IFG D Impaired fasting glucose
GLP D Glucagon-like peptide
GPR D G-protein couple receptor
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